4D Molecular Therapeutics, Inc. (FDMT) Shareholders’ equity 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) shareholders’ equity at each fiscal year-end, per SEC filings.
$505.7MFY2025 · since FY2019: -$73.0M → $505.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $505.7M | -1.0% |
| FY2024 | $510.6M | +65.9% |
| FY2023 | $307.8M | +33.1% |
| FY2022 | $231.3M | -27.5% |
| FY2021 | $319.1M | +24.5% |
| FY2020 | $256.4M | +451.4% |
| FY2019 | -$73.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice